Home » Stocks » QTRX

Quanterix Corporation (QTRX)

Stock Price: $36.61 USD -1.24 (-3.28%)
Updated Oct 30, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 1.15B
Revenue (ttm) 59.72M
Net Income (ttm) -44.74M
Shares Out 31.49M
EPS (ttm) -1.61
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 30, 2020
Last Price $36.61
Previous Close $37.85
Change ($) -1.24
Change (%) -3.28%
Day's Open 37.33
Day's Range 36.16 - 37.69
Day's Volume 119,468
52-Week Range 10.90 - 48.95

More Stats

Market Cap 1.15B
Enterprise Value 1.09B
Earnings Date (est) Nov 5, 2020
Ex-Dividend Date n/a
Shares Outstanding 31.49M
Float 22.61M
EPS (basic) -1.60
EPS (diluted) -1.61
FCF / Share -1.28
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 769,512
Short Ratio 2.87
Short % of Float 3.40%
Beta 1.77
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 19.30
PB Ratio 10.90
Revenue 59.72M
Operating Income -45.66M
Net Income -44.74M
Free Cash Flow -36.35M
Net Cash 59.72M
Net Cash / Share 1.90
Gross Margin 45.96%
Operating Margin -76.45%
Profit Margin -74.90%
FCF Margin -60.86%
ROA -20.22%
ROE -48.17%
ROIC -103.80%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

(14.72% upside)
Current: $36.61
Target: 42.00
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth50.76%64.52%30.08%44.38%-
Gross Profit26.8417.959.997.755.72
Operating Income-41.60-31.55-26.01-21.71-14.52
Net Income-40.80-31.54-27.02-23.17-15.94
Shares Outstanding25.0921.993.762.141.81
Earnings Per Share-1.63-1.43-8.30-12.89-11.19
Operating Cash Flow-26.19-28.72-22.11-17.74-12.52
Capital Expenditures-10.85-1.50-1.13-0.53-0.55
Free Cash Flow-37.03-30.22-23.24-18.27-13.07
Cash & Equivalents11045.4379.6829.672.32
Total Debt7.667.629.3810.249.73
Net Cash / Debt10337.8170.3019.43-7.40
Book Value12941.0765.87-115-88.64
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Quanterix Corporation
Country United States
Employees 248
CEO E. Kevin Hrusovsky

Stock Information

Ticker Symbol QTRX
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: QTRX
IPO Date December 7, 2017


Quanterix Corporation, a life sciences company, develops and markets digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. It also develops SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include kits, such as beads, capture and detector reagents, enzyme reagents, and enzyme substrates to run tests; and consumables, such as proprietary Simoa disks, cuvettes, and disposable tips. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sell its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.